Regarding the prognostic role of Mcl-1 expression, we performed a Kaplan–Meier study where we observed that high Mcl-1 levels were related to a lower disease free survival and a higher risk of patient recurrence, indicating that Mcl-1 could be a good prognostic marker of tumor aggressiveness (Figure 1e). The gene discussed is MCL1; the disease is neoplasm.